U.S. Markets closed

London Stock Exchange Group plc (LSEG.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
7,724.00+156.00 (+2.06%)
At close: 4:46PM BST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close7,568.00
Open7,606.00
Bid7,714.00 x N/A
Ask7,718.00 x N/A
Day's Range7,574.00 - 7,734.00
52 Week Range6,854.00 - 10,010.00
Volume430,880
Avg. Volume1,198,139
Market Cap38.982B
Beta (5Y Monthly)0.35
PE Ratio (TTM)64.96
EPS (TTM)118.90
Earnings DateAug 06, 2021
Forward Dividend & Yield0.75 (1.00%)
Ex-Dividend DateApr 29, 2021
1y Target EstN/A
  • Reuters

    UPDATE 1-Forced relocation of swaps clearing to EU would harm bloc, says LSE

    Forcing euro derivatives clearing to move from London to the European Union would bump up costs for customers and put EU firms at a competitive disadvantage to international peers, the London Stock Exchange Group argued in a note to clients. The EU is studying how trillions of euros in interest rate swaps positions could be shifted from LSEG's LCH clearing arm in London, where the bulk of the global market is cleared, to rival Deutsche Boerse's Eurex in Frankfurt.

  • Reuters

    Forced relocation of swaps clearing to EU would harm bloc, says London exchange

    Forcing euro derivatives clearing to move from London to the European Union would bump up costs for customers and put EU firms at a competitive disadvantage to their international peers, the London Stock Exchange Group said in a note to clients. "Restricting access to the EU economy and the Euro would place EU firms in competitive disadvantage against their peers and would also increase risk to financial stability both in the EU and more widely," LSEG said in a note issued on Friday.

  • Why Babylon Health chose 'more innovative' New York over London for listing
    Yahoo Finance UK

    Why Babylon Health chose 'more innovative' New York over London for listing

    London-based Babylon Health will join the Nasdaq through a $4.2bn SPAC deal in a snub to the UK.